Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 4
1(20.0%)
Phase 3
1(20.0%)
5Total
N/A(3)
Phase 4(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02448524Phase 3Unknown

Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)

Role: collaborator

NCT01735110Not ApplicableWithdrawn

PREPARE：Assessing the Safety and Efficacy of Radial Versus Femoral Approach PCI

Role: collaborator

NCT01704911Not ApplicableUnknown

Evaluate the Safety And Efficacy of the Transradial Coronary in Comparison With the Transfemoral Coronary Intervention

Role: lead

NCT01157455Phase 4Unknown

A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization

Role: lead

NCT00887211Not ApplicableUnknown

ProStent Coronary Drug-Eluting Stent

Role: lead

All 5 trials loaded